McCarter & English, LLP
Dihydropyrrolopyridine inhibitors of ROR-gamma
Provided are novel compounds of Formula (I): pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof, which are useful in the treatment of diseases and disorders mediated by RORγ. Also provided are pharmaceutical compositions comprising the novel compounds of Formula (I) and methods for their use in treating one or more inflammatory, metabolic, autoimmune and other diseases or disorders. 
Vitae Pharmaceuticals, LLC
A A C A A A A A A A A A A A A A A C A A A A A A A A A A A A A A A A A A A A A
A61P A61P C07D A61P A61P A61P A61P A61P A61P A61P A61P A61P A61P A61P A61P A61P A61P C07D A61P A61P A61P A61P A61P A61P A61P A61P A61P A61P A61P A61P A61P A61P A61P A61P A61P A61P A61P A61P A61P
inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional
Colin M. Yajun Zhijie Stephen D. Yi Lawrence Wayne Wei Linghang Lanqi David A. Andrew Jing Suresh B. Chengguo
Tice Zheng Liu Lotesta Fan Dillard Zhao Zhuang Jia Claremon Marcus Yuan Singh Dong